Tositumomab and iodine I 131 tositumomab (Bexaar).

Author(s): Srinivasan A, Mukherji SK

Affiliation(s): Department of Radiology, Division of Neuroradiology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA. ashoks@med.umich.edu

Publication date & source: 2011-04, AJNR Am J Neuroradiol., 32(4):637-8. Epub 2011 Mar 24.

Publication type: Review

Tositumomab and iodine I 131 tositumomab (Bexaar) therapeutic regimen targets monoclonal antibodies against the CD20 antigen expressed in non-Hodgkin lymphoma. This article reviews the mechanism of action and clinical indications for this regimen.